ETCCR Pharma Industry Clinical Research Experts

Sept. 22, 2011 - PRLog -- Established in 1970 by Dr. Robert M. Overholt, The Allergy, Asthma & Sinus Center is one of the country’s largest allergy practices. The practice boasts eight board certified allergists, one board certified dermatologist, fifteen nurse practitioners, fourteen locations, and continues to recruit additional providers expanding facilities on all fronts.(http://allergyasc.com) The clinical research division of the practice has successfully conducted pharmaceutical sponsored studies since 1994 in the areas of allergy, asthma, COPD, PIDD, and sinusitis. The growth and steady progress of the division has allowed the opportunity to change the name to East Tennessee Center for Clinical Research.

East Tennessee Center for Clinical Research, http://www.etccr.com,  has a team that is dedicated to the highest performance standards of conducting clinical research studies while maintaining a high level of care for subjects. The facility has an outstanding reputation among study sponsors and clinical research organizations for execution and management of clinical research studies.

Research Investigating Team

Paul M. Carter, MD
Principal Investigator
With over seven years experience conducting research, Dr. Paul M. Carter has been an investigator on research studies in allergy, asthma and internal medicine. He received his M.D. from the University of Tennessee at Memphis, served an internship at Methodist Hospital of Memphis, and completed his internal medicine residency at the University of Tennessee, Memphis. He completed his allergy fellowship at Henry Ford Hospital in Detroit, Michigan. Dr. Carter is board certified both in Internal Medicine and Allergy and Immunology. He is a Fellow of the American Academy of Allergy, Asthma, and Immunology (FAAAAI) and the American College of Allergy, Asthma and Immunology (FACAAI). He has been in full-time practice with The Allergy, Asthma & Sinus Center since 2002.

Ty L. Prince, MD
Principal Investigator
Dr. Ty Prince, a specialist in adult, adolescent and pediatric allergy, asthma and clinical immunology, is a graduate of the University of Tennessee Medical School in Memphis. He served as Chief Resident and Instructor in Internal Medicine at Erlanger Medical Center in Chattanooga in 1992-93 and completed a fellowship in Allergy and Immunology at the Medical College of Georgia in Augusta.  Dr. Prince is a Knoxville native who worked as a paramedic for local ambulance services and the Knoxville Rescue Squad prior to attending medical school. Dr. Prince is board certified in Allergy and Immunology. He is a Fellow of the American College of Allergy, Asthma and Immunology (FACAAI). He is also past President of the Tennessee Society of Allergy, Asthma and Immunology.

Joe Wiesniewski, MD
Principal Investigator
Dr. Joseph M. Wisniewski received his M.D. as a cum laude graduate from the University of Tennessee-Memphis and served his residency in internal medicine and pediatrics at LeBonheur Children's Hospital in Memphis. He joined the medical staff of The Allergy, Asthma & Sinus Center after a fellowship at Duke University Medical Center. Dr. Wisniewski is Board Certified in Allergy and Immunology.


Megan Partridge-Stauffer, MD
Principal Investigator
Dr. Megan Partridge Stauffer received her medical degree from Eastern Virginia Medical School, Norfolk. She completed her residency in Pediatrics at Johns Hopkins Hospital in Baltimore, Maryland, and her fellowship in Allergy and Immunology at Medical College of Georgia, Augusta. She is board certified in Allergy and Immunology and is a Fellow of the American Academy of Allergy, Asthma and Immunology (FAAAAI) and the American College of Allergy, Asthma and Immunology (FACAAI).


About the Research

East Tennessee Center for Clinical Research (ETCCR) http://www.etccr.com, has conducted more than 100 research studies in collaboration with various pharmaceutical companies. Every day, research uncovers new information. It is the foundation for drug and medical device approvals by the Food and Drug Administration (FDA). Our commitment is to provide a quality service while advancing medical technology. We are staffed by full-time board certified physicians who are experienced research investigators, complimented by dedicated research coordinators and support staff.

Choosing to volunteer for a research study is an important personal decision. We invite you to learn more about how you can be a participant. The following frequently asked questions provide an introduction to the clinical research process:

Clinical research studies are supervised evaluations of an investigational medication and/or medical device to determine its safety and effectiveness as a treatment for a specific disease or condition. Research is an important step in the development of medical therapies – therapies that may offer better treatments or even cures for a broad range of health problems.

Participants can play an active role in health care and gain access to new investigational treatments. Medical insurance coverage is not a requirement and participants receive study-related medical care, testing and study medication at no charge.

Adults, teenagers and children with the conditions being studied can participate in research studies. Each study has specific requirements. The investigator conducting the study will review each participant’s medical history and the study requirements to determine who is eligible.

An informed consent is a document that describes all study procedures, possible risks, side effects, benefits and alternative treatments. Before participants sign an informed consent, they are given an opportunity to have all of their questions answered by either an investigator or clinical research staff member. Even after signing the informed consent, participants may leave the study at any time.

If you live in the Knoxville, TN area and would like to participate or receive more information, you may contact ETCCR at (865) 212-4490 or at http://www.etccr.com.

# # #

East Tennessee Center for Clinical Research (ETCCR) has conducted more than 100 research studies in collaboration with various pharmaceutical companies.